Identifying patients at high risk for neutropenic complications during chemotherapy for metastatic breast cancer with doxorubicin or pegylated liposomal doxorubicin: The development of a prediction model

George Dranitsaris; Daniel Rayson; Mark Vincent; Jose Chang; Karen Gelmon; David Sandor; Greg Reardon

doi:10.1097/COC.0b013e318165c01d

Identifying patients at high risk for neutropenic complications during chemotherapy for metastatic breast cancer with doxorubicin or pegylated liposomal doxorubicin: The development of a prediction model

George Dranitsaris, Daniel Rayson, Mark Vincent, Jose Chang, Karen Gelmon, David Sandor, Greg Reardon

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	369-374
Number of pages	6
Journal	American Journal of Clinical Oncology: Cancer Clinical Trials
Volume	31
Issue number	4
DOIs	https://doi.org/10.1097/COC.0b013e318165c01d
Publication status	Published - Aug 2008
Externally published	Yes

ASJC Scopus Subject Areas

Oncology
Cancer Research

Keywords

Anthracyclines
Breast Cancer
Doxorubicin
Neutropenia
Prediction
Risk

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1097/COC.0b013e318165c01d

Cite this

Dranitsaris, G., Rayson, D., Vincent, M., Chang, J., Gelmon, K., Sandor, D., & Reardon, G. (2008). Identifying patients at high risk for neutropenic complications during chemotherapy for metastatic breast cancer with doxorubicin or pegylated liposomal doxorubicin: The development of a prediction model. American Journal of Clinical Oncology: Cancer Clinical Trials, 31(4), 369-374. https://doi.org/10.1097/COC.0b013e318165c01d

Identifying patients at high risk for neutropenic complications during chemotherapy for metastatic breast cancer with doxorubicin or pegylated liposomal doxorubicin: The development of a prediction model. / Dranitsaris, George; Rayson, Daniel; Vincent, Mark et al.
In: American Journal of Clinical Oncology: Cancer Clinical Trials, Vol. 31, No. 4, 08.2008, p. 369-374.

Research output: Contribution to journal › Article › peer-review

Dranitsaris, G, Rayson, D, Vincent, M, Chang, J, Gelmon, K, Sandor, D & Reardon, G 2008, 'Identifying patients at high risk for neutropenic complications during chemotherapy for metastatic breast cancer with doxorubicin or pegylated liposomal doxorubicin: The development of a prediction model', American Journal of Clinical Oncology: Cancer Clinical Trials, vol. 31, no. 4, pp. 369-374. https://doi.org/10.1097/COC.0b013e318165c01d

Dranitsaris G, Rayson D, Vincent M, Chang J, Gelmon K, Sandor D et al. Identifying patients at high risk for neutropenic complications during chemotherapy for metastatic breast cancer with doxorubicin or pegylated liposomal doxorubicin: The development of a prediction model. American Journal of Clinical Oncology: Cancer Clinical Trials. 2008 Aug;31(4):369-374. doi: 10.1097/COC.0b013e318165c01d

Dranitsaris, George ; Rayson, Daniel ; Vincent, Mark et al. / Identifying patients at high risk for neutropenic complications during chemotherapy for metastatic breast cancer with doxorubicin or pegylated liposomal doxorubicin : The development of a prediction model. In: American Journal of Clinical Oncology: Cancer Clinical Trials. 2008 ; Vol. 31, No. 4. pp. 369-374.

@article{da78e52f007544a5ba471c4294b30e38,

title = "Identifying patients at high risk for neutropenic complications during chemotherapy for metastatic breast cancer with doxorubicin or pegylated liposomal doxorubicin: The development of a prediction model",

keywords = "Anthracyclines, Breast Cancer, Doxorubicin, Neutropenia, Prediction, Risk",

author = "George Dranitsaris and Daniel Rayson and Mark Vincent and Jose Chang and Karen Gelmon and David Sandor and Greg Reardon",

year = "2008",

month = aug,

doi = "10.1097/COC.0b013e318165c01d",

language = "English",

volume = "31",

pages = "369--374",

journal = "American Journal of Clinical Oncology: Cancer Clinical Trials",

issn = "0277-3732",

publisher = "Lippincott Williams and Wilkins",

number = "4",

}

TY - JOUR

T1 - Identifying patients at high risk for neutropenic complications during chemotherapy for metastatic breast cancer with doxorubicin or pegylated liposomal doxorubicin

T2 - The development of a prediction model

AU - Dranitsaris, George

AU - Rayson, Daniel

AU - Vincent, Mark

AU - Chang, Jose

AU - Gelmon, Karen

AU - Sandor, David

AU - Reardon, Greg

PY - 2008/8

Y1 - 2008/8

KW - Anthracyclines

KW - Breast Cancer

KW - Doxorubicin

KW - Neutropenia

KW - Prediction

KW - Risk

UR - http://www.scopus.com/inward/record.url?scp=55449115686&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=55449115686&partnerID=8YFLogxK

U2 - 10.1097/COC.0b013e318165c01d

DO - 10.1097/COC.0b013e318165c01d

M3 - Article

C2 - 18845996

AN - SCOPUS:55449115686

SN - 0277-3732

VL - 31

SP - 369

EP - 374

JO - American Journal of Clinical Oncology: Cancer Clinical Trials

JF - American Journal of Clinical Oncology: Cancer Clinical Trials

IS - 4

ER -

Identifying patients at high risk for neutropenic complications during chemotherapy for metastatic breast cancer with doxorubicin or pegylated liposomal doxorubicin: The development of a prediction model

ASJC Scopus Subject Areas

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this